Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats

Area of Science:

• Neuroscience
• Gerontology
• Pharmacology

Background:

• Neurodegenerative diseases share pathways to neuronal injury via glutamate receptor overstimulation.
• This pathway may contribute to cognitive deficits observed in normal aging.
• Aged rats exhibit recognition memory deficits, indicating a need for therapeutic intervention.

Purpose of the Study:

• To investigate the effect of memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, on age-induced recognition memory deficits.
• To assess memantine's impact on oxidative damage in brain regions crucial for memory formation.

Main Methods:

• Male Wistar rats (24 months old) received daily injections of saline or memantine (20 mg/kg) for 21 days.
• Animals underwent a novel object recognition task one week post-treatment.
• Oxidative damage parameters were evaluated in the cortex and hippocampus.

Main Results:

• Memantine treatment restored normal recognition memory in aged rats.
• Saline-treated aged rats displayed significant long-term recognition memory deficits.
• Memantine administration reduced protein oxidative damage in the cortex and hippocampus.

Conclusions:

• Memantine effectively reverses age-induced recognition memory deficits in rats.
• Age-related cognitive decline is, at least partly, linked to NMDA receptor-mediated oxidative damage.
• Targeting NMDA receptor overactivation may offer a therapeutic strategy for age-related cognitive impairment.